← SynDRA
TOMELUKAST
SynDRA canonical compound SYN0005268 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | CYSLTR1 |
|---|
| Mechanism of action | Leukotriene receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- Leukotriene receptor antagonist
- CYSLTR1 MODULATOR
Drug classes
Cross-references
Synonyms
- LY-171833
- LY-171883
- LY171883
- Tomelukastum
- Lilly 171883
- DTXCID30344
- CHEBI:75310
- RefChem:898607
- Tomelukastum [INN-Latin]
- Compound LY171883
- MLS000069512
- NCGC00018122-08
- SMR000058555
- Tomelukast [USAN:INN]
- CAS-88107-10-2
- SR-05000000448
- BRN 4238438
- UNII-59762X5CLS
- MWYHLEQJTQJHSS-UHFFFAOYSA-N
- CPD000058555
- TOMELUKAST [INN]
- Opera_ID_1639
- Spectrum3_001918
- Spectrum5_001969
- Spectrum5_002024
- Tomelukast (USAN/INN)
- TOMELUKAST [USAN]
- SCHEMBL3944
- TOMELUKAST [MART.]
- CBiol_001912
- BSPBio_001402
- BSPBio_003516
- KBioGR_000122
- KBioSS_000122
- MLS000758272
- MLS001423988
- BML2-G05
- SCHEMBL5325407
Look up TOMELUKAST in the interactive SynDRA portal →